Evidence map›Paper›PMID 30010460›Full record

ArticleCell cycle (Georgetown, Tex.)2018

A membrane fusion protein, Ykt6, regulates epithelial cell migration via microRNA-mediated suppression of Junctional Adhesion Molecule A.

Nayden G Naydenov, Supriya Joshi, Alex Feygin, Siddharth Saini, Larisa Litovchick, Andrei I Ivanov

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. The Roles of Junctional Adhesion Molecules (JAMs) in Cell Migration.Frontiers in cell and developmental biology · 2022
    Review
  4. Oncoimmunology · 2021
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nayden G Naydenova Department of Inflammation and Immunity , Lerner Research Institute of Cleveland Clinic Foundation , Cleveland , OH , USA.ORCID 0000-0001-8037-6232
Supriya Joshib Department of Human and Molecular Genetics , Virginia Commonwealth University , Richmond , VA , USA.
Alex Feyginb Department of Human and Molecular Genetics , Virginia Commonwealth University , Richmond , VA , USA.
Siddharth Sainic Department of Internal Medicine , Virginia Commonwealth University , Richmond , VA , USA.ORCID 0000-0002-2813-9536
Larisa Litovchickc Department of Internal Medicine , Virginia Commonwealth University , Richmond , VA , USA.
Andrei I Ivanova Department of Inflammation and Immunity , Lerner Research Institute of Cleveland Clinic Foundation , Cleveland , OH , USA.
Virginia Commonwealth University · USCleveland Clinic · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Renato Martins · 1985 to 2026
$51.0M
VCU Neuroscience Center Core GrantP30NS047463 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI POVLISHOCK, JOHN T · 2003 to 2013
$5.0M
NCI NIH HHS P30 CA016059NINDS NIH HHS P30 NS047463
6 · The paper itself

Abstract

Vesicle trafficking regulates epithelial cell migration by remodeling matrix adhesions and delivering signaling molecules to the migrating leading edge. Membrane fusion, which is driven by soluble N-ethylmaleimide-sensitive factor associated receptor (SNARE) proteins, is an essential step of vesicle trafficking. Mammalian SNAREs represent a large group of proteins, but few have been implicated in the regulation of cell migration. Ykt6 is a unique SNARE existing in equilibrium between active membrane-bound and inactive cytoplasmic pools, and mediating vesicle trafficking between different intracellular compartments. The biological functions of this protein remain poorly understood. In the present study, we found that Ykt6 acts as a negative regulator of migration and invasion of human prostate epithelial cells. Furthermore, Ykt6 regulates the integrity of epithelial adherens and tight junctions. The observed anti-migratory activity of Ykt6 is mediated by a unique mechanism involving the expressional upregulation of microRNA 145, which selectively decreases the cellular level of Junctional Adhesion Molecule (JAM) A. This decreased JAM-A expression limits the activity of Rap1 and Rac1 small GTPases, thereby attenuating cell spreading and motility. The described novel functions of Ykt6 could be essential for the regulation of epithelial barriers, epithelial repair, and metastatic dissemination of cancer cells.

Indexed as

Cell MovementMembrane FusionCell Line, TumorDown-RegulationEpithelial CellsHumansIntercellular JunctionsJunctional Adhesion Molecule AMaleMicroRNAsProstatic Neoplasmsrac1 GTP-Binding ProteinR-SNARE ProteinsShelterin ComplexTelomere-Binding ProteinsUp-RegulationJunctional Adhesion Molecule AMicroRNAsMIRN145 microRNA, humanrac1 GTP-Binding ProteinRAC1 protein, humanR-SNARE ProteinsShelterin ComplexTelomere-Binding ProteinsTERF2IP protein, humanYKT6 protein, humanJunctionsSNARE; motility

Identifiers

PMID30010460
PMCPMC6133332
OpenAlexW2883131432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.